|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 800 I STREET, NW |
Address2 |
|
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 3173-12
|
||||||||
|
6. House ID# 333530000
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: SUSAN POLAN |
Date | 1/18/2018 9:08:57 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Increase funding for the Centers for Disease Control and Prevention in FY 2018.
Support FY 2018 funding for newborn screening programs at CDC and HRSA.
Increase funding for the Health Resources and Services Administration in FY 2018.
Support full funding for HIV/AIDS programs at HRSA and CDC.
Support of full funding for HRSAs health professions and nursing workforce development programs in fiscal year 2018.
Support adequate funding for the National Health Service Corps.
Support adequate FY 2018 funding for the Agency for Healthcare Research and Quality.
Oppose appropriations riders to block or delay FDA regulation of tobacco products.
Oppose cuts to CDC's Office of Smoking and Health.
Oppose appropriations riders to weaken Clean Air Act regulations.
Support ample funding to combat the Zika virus in the Fiscal Year 2018 appropriations bills.
Oppose cuts and supporting adequate funding for NDD programs in the FY 2018 appropriations process.
Support adequate FY 2018 funding for the National Center for Health Statistics.
Support adequate FY 2018 funding for CDC's National Center for Chronic Disease Prevention and Health Promotion.
Support adequate FY 2018 funding for WIC.
Proposed recommendations for a public health emergency response fund if included in the FY2018 Labor-Health and Human Services and Education Appropriations bill.
Support strong funding for the Office of National Drug Control Policy.
Strong funding for programs critical to public health preparedness.
Support adequate funding for CDC's National Center for Environmental Health.
Support emergency supplemental funding for critical public health, healthcare, and behavioral health services to address the ongoing crises in states and territories impacted by recent hurricanes.
Oppose H. Con. Res. 71, the House FY 18 budget resolution.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Support for the extension of health care safety net programs including CHIP, community health centers, National Health Service Corps.
Oppose Graham-Cassidy Affordable Care Act repeal proposal.
Oppose efforts to repeal the Prevention and Public Health Fund.
Oppose CHAMPIONING HEALTHY KIDS Act, cuts to Prevention and Public Health Fund.
Oppose efforts to cap or block grant Medicaid and end the Medicaid expansion under the Affordable Care Act.
Support comprehensive over-the-counter monograph reform efforts.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), White House Office, President of the U.S.
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
Support the Climate Change Health Protection and Promotion Act.
Oppose H.R. 806, the Ozone Standards Implementation Act.
Oppose H.R. 5 and S. 951, the Regulatory Accountability Act of 2017.
Oppose H.R. 998, the SCRUB Act; H.R. 1004, the Regulatory Integrity Act; and H.R. 1009, the OIRA Insight, Reform, and Accountability Act.
Oppose the EPA Science Advisory Board Reform Act of 2017 and the Honest and Open New EPA Science Treatment Act of 2017.
Oppose executive order 13771 Reducing Regulation and Controlling Regulatory Costs over concerns that it could jeopardize public regulations that safeguard safety and health.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
Support adequate funding for the federal response to the opioid epidemic.
17. House(s) of Congress and Federal agencies Check if None
Office of Management & Budget (OMB), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Office of Natl Drug Control Policy (NDCP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Oppose H.R. 3529, the WIC Improvement Act.
Support nutrition facts label compliance date.
Oppose S. 261 and H.R. 772, the Common Sense Nutrition Disclosure Act of 2017, legislation that would weaken menu labeling regulations.
Support Food and Drug Administration moving forward with voluntary sodium reduction targets for the food manufacturing industry.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), U.S. SENATE, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Oppose H.J.Res. 43 and S.J.Res. 13, legislation that would would overturn the U.S.
Department of Health and Human Services final rule updating the regulations that apply to the Title X Family Planning Program.
Oppose any effort to exclude Planned Parenthood health centers from participating in federal health programs.
Urge the Office of Management and Budget to support family planning and sexual health care services in its FY 2018 budget request.
Support a strong national paid family and medical leave policy.
Oppose H.R. 36, the Pain-Capable Unborn Child Protection Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
Oppose H.R. 3668, the Sportsman Heritage and Recreational Enhancement Act.
Support bipartisan legislation to require universal background checks for firearm purchases and federal funding for gun violence prevention surveillance and research.
Support the Fix NICS Act of 2017, legislation to strengthen the accuracy of the National Instant Criminal Background Check System.
Oppose H.R. 38, the Concealed Carry Reciprocity Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Oppose tobacco-related policy riders on appropriations bills.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Oppose H.R. 1, the Tax Cuts and Jobs Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |